Jubilant Life Sciences working on reducing its debt through internal accruals against taking fresh loan will serve well for its future growth says Surajit Pal, Prabhudas Lilladher.
first published: Aug 10, 2016 11:36 am
A collection of the most-viewed Moneycontrol videos.

Nifty Snaps 6-Day Winning Streak As Markets Get In Consolidation Mode| Closing Bell Live

Kenneth Andrade picks three unusual, ignored sectors to bet on in Samvat 2082

Nifty Likely To Consolidate Until It Clears 26,000 Mark Decisively | Opening Bell Live

Nifty Slips Over 150 Points From Day's High But Gains For 6th Day| IT Stocks Surge|Closing Bell Live
You are already a Moneycontrol Pro user.

